Article
Drug resistance among HIV-infected pregnant women receiving antiretrovirals for prophylaxis.
AIDS (London, England) - 11 Jan 2007
Duran Adriana S, Losso Marcelo H, Salomón Horacio, Harris D Robert, Pampuro Sandra, Soto-Ramirez Luis E, Duarte Geraldo, de Souza Ricardo S, Read Jennifer S
Abstract excerpt
OBJECTIVE: To quantify primary resistance mutations (PRMs) among HIV-1-infected women receiving antiretroviral therapy (ART) for prevention of mother-to-child transmission (MTCT). METHODS: Peripheral blood mononuclear cell samples from HIV-1-infected women enrolled in a prospective cohort study in Argentina, the Bahamas, Brazil, and Mexico (NISDI Perinatal Study) were assayed for PRMs. Eligible women were those...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
